In an interview with ET Now, Kiran Mazumdar Shaw , CMD, Biocon , says it has been a huge investment for both Mylan and Biocon but it is now going to pay off both the companies and we look forward to basically getting a sizeable market share. Read more here: It is pay-off time for investment in biosimilars: Kiran Mazumdar Shaw, Biocon
Read More Here: It is pay-off time for investment in biosimilars: Kiran Mazumdar Shaw, Biocon
No comments:
Post a Comment